# Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity

> **NCT03139318** · NA · TERMINATED · sponsor: **University of Arkansas** · enrollment: 1 (actual)

## Conditions studied

- Osteosarcoma in Children
- Radiation Toxicity

## Interventions

- **RADIATION:** GRID radiotherapy

## Key facts

- **NCT ID:** NCT03139318
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-07-25
- **Primary completion:** 2018-08-29
- **Final completion:** 2018-08-29
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Due to COVID-19 and the resulting administrative issues, it is not feasible to continue the study.
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03139318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03139318, "Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03139318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*